Examinando por Autor "Chedraui, Peter"
Mostrando 1 - 3 de 3
Resultados por página
Opciones de ordenación
- PublicaciónSólo datosAssociation between depressive symptoms and adherence to highly active antiretroviral therapy in HIV-positive women is dependent of menopausal status: a secondary analysis from a Peruvian series(Elsevier Inc., 2019-06) Arriola Montenegro, José; Cutimanco Pacheco, Victor; Zeta Solis, Ludwing; Niño García, Roberto; Rodríguez Morales, Alfonso; Chedraui, Peter; Mezones Holguin, EdwardThe adherence to highly active antiretroviral therapy (HAART) is key to the therapeutic success of HIV patients and associated to depressive symptoms (DS) in several studies. However, there are few publications regarding mid-aged women; a period in which the menopausal status could play an important role.
- PublicaciónSólo datosSexual dysfunction was associated to depressed mood in mid-aged women from Paraguay(Elsevier B.V., 2019-06) Sánchez Zarza, Sandra; Mezones Holguin, Edward; Soto Becerra, Percy; Pérez López, Faustino R.; Gavilanes, Antonio W.D.; Chedraui, PeterReports indicate that depressive symptoms may affect sexuality of mid-aged women and vice versa sexual problems tend to aggravate depression. Despite this, information addressing this association drawn from mid-aged Paraguayan women is scarce. This was a cross-sectional study in which sexually active women from Asunción (Paraguay, aged 40 to 60 years) were surveyed with the 6 ítem Female sexual Function Index (FSFI-6), the 10-ítem Center for Epidemiological Studies Depression Scale (CESD-10) and a general questionnaire containing personal and partner data.
- PublicaciónSólo datos“Warmi” and the menopause: synthesis of the evidence after 10 years of commercialization(Elsevier Inc., 2019-06) Mezones Holguin, Edward; Soto Becerra, Percy; Danckers, Luis; Chedraui, PeterWarmi, a natural supplement containing glucosinolates, beta-sitosterol and flavonoid citrus, is used for the treatment of menopausal symptoms. In this report we synthesize the accumulated evidence from preclinical and clinical studies regarding its efficacy and safety.